Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them
Background and objective Adenocarcinoma is the most common type of lung cancer. It has been clinically evaluated that therapiestargeting against the epidermal growth factor receptor (EGFR) as the clinical standard first-line treatment. The response and outcome of EGFR-tyrosine kinase inhibitors (TKI...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Chinês |
| Pubblicazione: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-05-01
|
| Serie: | Chinese Journal of Lung Cancer |
| Soggetti: | |
| Accesso online: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.05.06 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|